Introducing the Successes of Antibody Enzyme Conjugates with Oxidized LDL as a Novel Payload in Inactivated P53 Tumors
Time: 3:30 pm
day: Conference Day One
Details:
- Introducing data compared to traditional ADCs for a new therapeutic agent – an antibody enzyme conjugate or AEC
- Introducing a new payload – oxidized LDL generated in the tumor micro environment
- Demonstrating independence from p53 through showing efficacy in both p53 active and inactive tumors
